Healthcare Companies to Face Intensifying Scrutiny of COVID-19 Provider Relief Funds from Government and Whistleblowers
In its 11th annual Healthcare Fraud & Abuse Review, Bass, Berry & Sims provides analysis of healthcare fraud enforcement actions and False Claims Act (FCA) developments probing COVID-19 relief, telehealth, opioid enforcement and other areas. In 2022, the federal government set the stage for wider scrutiny of billions of dollars in pandemic relief funds for…